MicroRNA and Markers and Therapeutic Response to Romosozumab and Abaloparatide in Postmenopausal Osteoporosis

Abroad (travel likely)Recruiting

Conditions

Osteoporosis · Menopause

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Istituto Auxologico Italiano IRCCS, Miano, Lombardy, Italy
Contact: Study coordinator (Sabrina Corbetta, Prof.) · s.corbetta@auxologico.it · +39-02619111
IRCCS Ospedale Galeazzi Sant'Ambrogio, Milan, Lombardy, Italy
Contact: Study coordinator (Gregorio Guabello, MD) · gregorio.guabello@gmail.com

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Radiographic Cortical Thickness of the Humerus in Detecting Post-Stroke Regional Bone Loss

Hemiparesis After Stroke · Dual Energy X-ray Absorptiometry · Osteoporosis

Abroad (travel likely)Recruiting

Istanbul, Turkey (Türkiye)

People With Osteoporosis Can Walk-BEST to Reduce Fall and Fracture Risk

Osteoporosis

Abroad (travel likely)Recruiting

Montreal, Canada

GLP-1R Actions on Muscle and the Skeleton

Musculoskeletal Abnormalities · Obesity · Sarcopenic Obesity

Abroad (travel likely)RecruitingPHASE4

Baton Rouge, United States

The Osteoporotic Fracture Classification-based Scoring System for Treatment Decision in Thoracolumbar Osteoporotic Fractures

Osteoporotic Fractures · Osteoporosis

Abroad (travel likely)Recruiting

San Francisco, United States · Philadelphia, United States